Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleeping through Menopause
2024-512071-12-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of estradiol and progesterone in Insomnia, menopause and Perimenopausal mood disturbance, sponsored by Amsterdam University Medical Center. Primary endpoint: Change in insomnia severity. Planned start Mar 2025; status: authorised.
02
Drugs
estradiolprogesterone
03
Conditions
InsomniamenopausePerimenopausal mood disturbance
Beyond the preview
Go deeper on 2024-512071-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512071-12-00.